Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on August 17th, 2013% (Ged Carroll/Flickr)
As regular readers may notice, we’ve changed the name of this blog to Science and Enterprise. Let me explain why we did it.
Earlier this month we received a letter from a trademark attorney representing Science Business Publishing Ltd. that appears to be a consulting company based in the U.K. and publisher . . . → Read More: Welcome Science and Enterprise. Farewell Science Business.
By Alan, on August 16th, 2013% ERCP image showing the biliary tree and the main pancreatic duct (Wikipedia)
A new challenge on InnoCentive is looking for simpler tools or methods for imaging or conducting treatments in small ducts connected to the liver, gall bladder, or pancreas. The competition has a a prize purse of $25,000 and a deadline of 13 . . . → Read More: Simpler Internal Organ, Duct Imaging Sought in Challenge
By Alan, on August 16th, 2013% Jay Aikat, left, and Mike Reiter of the University of North Carolina at Chapel Hill, are among the researchers investigating better security for cloud computing (University of North Carolina, Chapel Hill)
National Science Foundation is funding new research to better secure the nation’s health information technology, simplify and improve control of security for cloud . . . → Read More: NSF Awards $20 Million for Cyber Security, Privacy R&D
By Alan, on August 15th, 2013% (HHS.gov)
A late-stage clinical trial shows the drug linagliptin, marketed by Boehringer Ingelheim and Eli Lilly and Company, helps elderly patients with type 2 diabetes lower their blood glucose levels. Researchers from Boehringer Ingelheim and University of Birmingham in the U.K. describe their findings online this week in the journal The Lancet (paid . . . → Read More: Trial Shows Glucose-Lowering Drug Effective with Elderly
By Alan, on August 15th, 2013% Berkeley Lab team, L-R, Guillermo Garcia, Delia Milliron, and Anna Llordés (Lawrence Berkeley National Laboratory )
Chemists and materials scientists at Lawrence Berkeley National Laboratory in California created a window coating of nanocrystals that can dynamically control the sunlight passing through the window and thus improve a building’s energy efficiency. The team led . . . → Read More: Nanotech Window Coating Controls Building Light, Heat
By Alan, on August 14th, 2013% (National Institutes of Health)
Medical researchers with American College of Surgeons devised an online system that calculates an individual’s risk of developing complications for nearly all kinds of surgery. The team led by Karl Bilimoria, director of the Surgical Outcomes and Quality Improvement Center at Northwestern University in Chicago, with colleagues from the . . . → Read More: Calculator Estimates Individual Surgical Complications Risk
By Alan, on August 14th, 2013% PillCam SB3 (Given Imaging Ltd.)
The Food and Drug Administration cleared for sale in the U.S. a new version of a tiny camera in a capsule, made by Given Imaging Ltd. in Yoqneam, Israel, and swallowed by patients to diagnose gastrointestinal (GI) conditions. The company expects its PillCam SB3 to be available in . . . → Read More: FDA Clears Enhanced Capsule Camera for GI Disorders
By Alan, on August 13th, 2013% Prototype ambient backscatter devices (University of Washington)
Computer scientists and engineers at University of Washington in Seattle developed a wireless process that harnesses existing television and cell phone signals as sources of power and a way of communicating. The team led by computer science professors Shyam Gollakota and Joshua Smith describes the process in . . . → Read More: TV, Cellular Signals Harnessed for Power, Communications
By Alan, on August 13th, 2013% Gut-on-a-chip (Wyss Institute, Harvard University)
The U.S. Food and Drug Administration awarded a contract to a Harvard University lab for simulated organ devices to test radiation disease countermeasures. The $5.6 million award will fund the work of Harvard’s Wyss Institute for Biologically Inspired Engineering from FDA’s research and development program on regulatory science . . . → Read More: FDA Funds Organ-on-Chip to Test Radiation Disease Treatments
By Alan, on August 12th, 2013% Omar Ishrak (Medtronic Inc.)
Medtronic Inc., a medical device company in Minneapolis, Minnesota, is buying Cardiocom, a developer of telemedicine systems in nearby Chanhassen, Minnesota, in an all-cash transaction valued at $200 million. Medtronic’s devices currently help treat cardiac and vascular diseases, diabetes, and neurological and musculoskeletal disorders.
Cardiocom, founded in 1999 and privately . . . → Read More: Medtronic Acquires Telemedicine Systems Developer
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.